Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

How AI is Transforming Clinical Trials
AI is already reshaping the clinical trials industry and that transformation looks set to continue over the next five years. New technologies will enable the development of more personalized medicines, empower more responsive trial designs and improve informed decision making by unlocking new data insights. read more
From Service Provider to Strategic Partner
As drug development grows more complex and timelines compress, sponsors require CDMO relationships built on integration, flexibility, and shared accountability read more
How Real-Time Data Analytics Can Address Common Pain Points in Clinical Trials
Major issues in clinical oversight are latency and heterogeneity across systems including formats, identifiers, coding conventions, and timing of updates. read more
Leveraging AI and ML to Optimize Drug Discovery – a CRO Perspective
CROs supporting early-stage drug discovery projects are establishing their own internal AI platforms to address their clients’ needs in an evolving field. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Phanes, Merck Expand Trial Pact to Test CD47 Bispecific with KEYTRUDA in 1L Biliary Tract Cancer
Tuesday, July 21, 2026
Phanes Therapeutics has expanded its clinical trial collaboration and supply agreement with Merck to evaluate spevatamig in combination with KEYTRUDA ... read more
Lonza, Engitix Sign License Deal to Advance ECM-Targeted ADC Therapies
Tuesday, July 21, 2026
Lonza and Engitix have entered a licensing agreement aimed at advancing a new generation of antibody-drug conjugates (ADCs) that target the ... read more
Redwire Opens Indiana Space R&D Hub to Advance Drug Development and Human Health
Tuesday, July 21, 2026
Redwire Corporation has opened a new 30,000 square foot, state-of-the-art research and microgravity payload development facility in Georgetown, ... read more
CDMO eXmoor Pharma, Evox Complete Tech Transfer for Exosome Gene Editing Platform
Tuesday, July 21, 2026
eXmoor Pharma and Evox Therapeutics have completed a technology transfer program for Evox’s exosome-enabled gene editing platform, including its MSH3-... read more
Clinigen Names Industry Veteran as New CEO
Tuesday, July 21, 2026
Clinigen has appointed Greg Skalicky as Group Chief Executive Officer, effective July 20, 2026, succeeding Dr. Varun Sethi, who has served as Acting ... read more